MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12070-025-05631-0

Медицинская библиотека · Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2025

Comparative Mortality and Risk Analysis in Mucormycosis Cases: Pre-Pandemic Versus COVID-19 Association.

Janipour Masoud, Shahriari Alireza, Faramarzi Ali, Owji Seyed Hossein, Golshannia Mohammad Ehsan, Kherad Maryam, Rahimi Maryam, Hajianpour Vahid, Khademi Behzad, Babaei Amirhossein

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

This study aims to compare the clinical profiles, outcomes, and mortality-related risk factors of COVID-19-associated mucormycosis (CAM) with cases identified before the pandemic. Additionally, it seeks to evaluate the impact of the COVID-19 pandemic on the epidemiology and severity of mucormycosis infections.

STUDY

DESIGN

Retrospective, observational study.

SETTING

The study was conducted across multiple medical centers in Shiraz, Iran.

METHODS

We reviewed clinical data of patients diagnosed with mucormycosis before and during the COVID-19 pandemic. The study included a detailed analysis of demographic profiles, clinical characteristics, risk factors, treatment outcomes, and mortality. Mortality-related risk factors were specifically analyzed through logistic regression models to identify predictors of poor outcomes in CAM patients.

RESULTS

The study included 122 cases of mucormycosis, with 85 cases associated with COVID-19. Patients with CAM showed higher prevalences of diabetes mellitus and hypertension compared to pre-pandemic cases, while malignancies were higher in peri-pandemic cases than in CAM cases (p < 0.05). CAM cases also demonstrated significantly higher in-hospital mortality (23.1%) compared to pre-pandemic cases (7.7%). Elevated platelet counts and the presence of periorbital edema were more commonly observed in CAM patients. Mortality-based analysis indicated that malignancies and high platelet counts were significant predictors of mortality in CAM patients.

CONCLUSION

COVID-19 has markedly affected the severity and mortality of mucormycosis, with CAM cases showing worse outcomes than pre-pandemic incidences. Our study emphasizes the need for aggressive management and increased awareness of risk factors to enhance survival rates in CAM patients during the pandemic.

Для цитирования: Janipour Masoud, Shahriari Alireza, Faramarzi Ali, Owji Seyed Hossein, Golshannia Mohammad Ehsan, Kherad Maryam, Rahimi Maryam, Hajianpour Vahid, Khademi Behzad, Babaei Amirhossein. Comparative Mortality and Risk Analysis in Mucormycosis Cases: Pre-Pandemic Versus COVID-19 Association.. Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India. 2025. DOI: 10.1007/s12070-025-05631-0.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.